Evaluation of the efficacy and safety of Melatonin in moderately ill patients with COVID-19: A structured summary of a study protocol for a randomized controlled trial

OBJECTIVES: We will evaluate the efficacy and safety of Melatonin, compared to the standard therapeutic regimen on clinical symptoms and serum inflammatory parameters in patients with confirmed COVID-19, who are moderately ill. TRIAL DESIGN: This is a single-center, randomized, double-blind, placebo...

Descripción completa

Detalles Bibliográficos
Autores principales: Ziaei, Ava, Davoodian, Parivash, Dadvand, Habib, Safa, Omid, Hassanipour, Soheil, Omidi, Mahmoud, Masjedi, Moein, Mahmoudikia, Fahime, Rafiee, Bahareh, Fathalipour, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7586647/
https://www.ncbi.nlm.nih.gov/pubmed/33106171
http://dx.doi.org/10.1186/s13063-020-04737-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7586647/
https://www.ncbi.nlm.nih.gov/pubmed/33106171
http://dx.doi.org/10.1186/s13063-020-04737-w

Ejemplares similares